UnitedHealth Group 株価情報 (NYSE: UNH)

最新ニュース UnitedHealth Group (NYSE:UNH) 株価情報

UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Inc

EC Healthcare

United Hampshire US REIT

On Thursday,&nbsp;UnitedHealth Group&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)&nbsp;reported the fourth-quarter 2024 earnings and <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/43025159/unitedhealth-q4-earnings-revenue-falls-short-medical-ratio-rises-to-85-5-stock-falls" rel="noreferrer noopener">reaffirmed 2025 guidance</a>.
The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the&nbsp;consensus of $6.72. Revenues increased 6.8% year over year to $100.8 billion, missing the&nbsp;consensus of $101.76 billion.
KeyBanc Capital Markets says the third-quarter results included some unusual fluctuations but did not change the overall outlook.
One-time revenue factors drove the higher medical loss ratio (MLR), while core cost trends stayed consistent, impacted by hospital coding and specialty drug expenses.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/43041254/unitedhealth-ceo-highlights-hospitals-doctors-pharmas-role-in-soaring-health-care-costs" rel="noreferrer noopener">UnitedHealth CEO Highlights Hospitals, Doctors, Pharma&#8217;s Role In Soaring Health Care Costs</a>
The MLR is the percentage of insurance premium dollars spent on reimbursement for clinical services and activities to improve health care quality.
KeyBanc maintains the Overweight rating with a price forecast of $650.
Analyst Matthew Gillmor says key positives include favorable Medicare Advantage (MA) Annual Enrollment Period (AEP) performance, highlighting near-record retention rates and a strong mix of members, including dual-eligibles and returning customers.
Gillmor says this positive trend could boost margins since Medicare Advantage (MA) members in their second year or beyond are typically more profitable. In 2024, UnitedHealth faced challenges from higher member churn due to competitors offering enhanced supplemental benefits.
The analyst writes the trends support the view of an EPS growth acceleration for UnitedHealth, potentially aided by a better MA rate environment under the upcoming Trump administration.
KeyBanc remains confident EPS growth can return to the 13-16% range by 2026, supporting a valuation recovery to historical multiples around 19x earnings versus 17x currently.
Meanwhile, Cantor Fitzgerald shared a cautiously optimistic view on UnitedHealth Group's 2025 outlook following discussions with management, describing the company's guidance as conservatively positioned.
Analyst Sarah James highlighted the firm&#8217;s confidence, stating, &#8220;We continue to view UNH as our Top Pick for 2025, and the current 15.3x multiple as undervaluing the company&#8217;s strong business positioning and diversified portfolio.&#8221;
Price Action: UNH stock is up 1.12% at $516.30 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43061153/walmart-launches-eco-friendly-home-office-campus-details" target="_blank" rel="noreferrer noopener">Walmart Launches Eco-Friendly Home Office Campus: Details</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Large Cap

News

Health Care

Analyst Ratings

General

UnitedHealth's Strong Member Loyalty Powers Analyst Growth Forecasts

Barclays analyst Andrew Mok maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and lowers the price target from $655 to $642.

Price Target

Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $642

Trading Ideas

Live On CNBC, Kevin Simpson Announces Covered Call Strategy On United Health Group

UnitedHealth Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) short percent of float has risen 27.14% since its last report. The company recently reported that it has 8.18 million shares sold short, which is 0.89% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>UnitedHealth Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737128717_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UnitedHealth Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UnitedHealth Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, UnitedHealth Group's peer group average for short interest as a percentage of float is 5.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(UNH) - Analyzing UnitedHealth Group's Short Interest

Keybanc analyst Steve Barger reiterates UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and maintains $650 price target.

Reiteration

Keybanc Reiterates Overweight on UnitedHealth Group, Maintains $650 Price Target

Cantor Fitzgerald analyst Sarah James reiterates UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and maintains $700 price target.

Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $700 Price Target

U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29. The Dow decreased by almost 0.2% to 43,153.13, while the S&amp;P 500 fell 0.2% to 5,937.34.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Apple Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
Apple&#8217;s shares fell 4.04%, closing at $228.26, with an intraday high of $238.01 and a low of $228.03. The stock is trading between its 52-week high of $260.09 and low of $164.08. The decline follows a report indicating a <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43042851/apple-shares-dip-as-iphone-sales-in-china-decline-sharply-in-2024-whats-going-on">significant drop</a> in iPhone sales in China, with Canalys data showing a 17% annual decrease in shipments, marking Apple&#8217;s largest sales drop in the region.
Rivian Automotive Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>)
Rivian&#8217;s stock rose 3.59% to close at $14.44, reaching an intraday high of $14.66 and a low of $13.95. The stock&#8217;s 52-week range is $18.86 to $8.26. The increase came after Rivian finalized a&nbsp;<a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43045600/rivian-stock-is-racing-higher-after-hours">loan agreement</a>&nbsp;with the U.S. Department of Energy for up to $6.6 billion, aimed at supporting the construction of a new manufacturing facility in Georgia.
UnitedHealth Group, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
UnitedHealth shares dropped 6.04%, closing at $510.59, with a high of $539.84 and a low of $510. The stock&#8217;s 52-week high is $630.73, and the low is $436.38. The decline follows mixed financial results, with&nbsp;<a href="https://www.benzinga.com/general/health-care/25/01/43041254/unitedhealth-ceo-highlights-hospitals-doctors-pharmas-role-in-soaring-health-care-costs">earnings exceeding estimates</a>&nbsp;but revenue falling short by nearly $1 billion, amid challenges like Medicare funding reductions.
Biomerica, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>)
Biomerica&#8217;s stock surged 101.71% to $0.71, with an intraday high of $1.27 and a low of $0.56. The stock&#8217;s 52-week range is $1.35 to $0.24. The dramatic rise follows the approval of its&nbsp;<a href="https://www.benzinga.com/general/health-care/25/01/43033027/biomerica-stock-trades-200-higher-after-prostate-screening-test-receives-approval">Fortel Prostate Specific Antigen Screening Test</a>&nbsp;by the United Arab Emirates Ministry of Health and Prevention.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s shares decreased by 3.36%, closing at $413.82, with a high of $424 and a low of $409.13. The stock trades between a 52-week high of $488.54 and a low of $138.8. The decline comes as an analyst from <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43036902/tesla-stock-valuation-analyst-flags-long-term-growth-opportunities-robotaxis-fsd">Goldman Sachs</a> highlighted Tesla&#8217;s <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43036902/tesla-stock-valuation-analyst-flags-long-term-growth-opportunities-robotaxis-fsd">monetization opportunities</a> with robotaxis and full self-driving technology, maintaining a Neutral rating.
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.

Equities

Markets

AAPL

BMRA

RIVN

TSLA

Apple, Rivian, Unitedhealth, Biomerica, Tesla: Why These 5 Stocks Are On Investors' Radars Today

UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported its financial results on Thursday after a tumultuous fourth quarter that included the murder of UnitedHealthcare division CEO Brian Thompson and broad public outrage over the <a href="https://www.benzinga.com/general/health-care/24/12/42744629/unitedhealth-group-ceo-reportedly-says-company-will-hit-financial-records-execs-murder-public-outcry-are-backdrop-for-q4-earnings">nation's health care system.&nbsp;</a>
What To Know: UnitedHealth posted mixed<a href="https://www.benzinga.com/general/health-care/25/01/43025159/unitedhealth-q4-earnings-revenue-falls-short-medical-ratio-rises-to-85-5-stock-falls"> financial results</a> for the quarter, beating earnings estimates, but missing on revenue by nearly $1 billion. The insurer also reported that its full-year medical care ratio rose to 85.5%, up from 83.2% in 2023,  due to CMS&#8217;s Medicare funding reductions, the timing of Medicaid redeterminations and the cyberattack on UnitedHealth&#8217;s subsidiary Change Healthcare. 
Read Next: <a href="https://www.benzinga.com/news/legal/25/01/42979220/biden-announces-more-student-loan-forgiveness-bringing-debt-relief-to-nearly-5-million-borrowers">Biden Announces More Student Loan Forgiveness, Bringing Debt Relief To Nearly 5 Million Borrowers</a>
Q4 Earnings Call: UnitedHealth CEO Andrew Witty held a conference call with analysts following the earnings release and opened the call with a tribute to Thompson.&nbsp;
"He would dive in with passion and caring to find solutions to improve experiences, whether for an individual consumer, an employer or a public health agency," Witty said of Thompson, as <a href="https://insurancenewsnet.com/innarticle/unitedhealth-reports-29m-revenue-bump-in-2024-ceo-rips-costly-system">reported by</a> Insurance NewsNet.&nbsp;
The UnitedHealth CEO addressed the public outcry over the high costs of health care and health insurance in the U.S. and pointed to hospitals, doctors and pharmaceutical companies as the cause. 
"Health care costs more in the U.S. because the price of a single procedure, visit or prescription, is higher here than it is in other countries," Witty said. 
"There are participants in the system who benefit from these high prices. Lower-cost, equivalent quality sites of service, for example, can be good for consumers and patients, but threaten revenue streams for organizations that depend on charging more for care," he added.&nbsp;
Witty also staunchly defended pharmacy benefit managers, which have come under scrutiny and criticism as being at least <a href="https://www.benzinga.com/government/regulations/25/01/43010888/ftc-says-unitedhealth-cvs-cigna-make-billions-via-pbms-on-specialty-drugs">partially responsible</a> for high prescription prices. 
"PBMs are really the only effective mechanism across the system which really holds the pharmaceutical company to account once it chooses to set its price," Witty said. "The PBM is there to try and hold that to account and negotiate on behalf of employers, unions, states and others, to try and bring down those prices."&nbsp;
The CEO also announced that UnitedHealth's OptumRx PBM will return 100% of rebates from drug companies back to its customers by 2028, up from 98% currently. 
UNH Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, UnitedHealth shares finished 6.04% lower at $510.59 on Thursday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43007213/experts-see-the-fed-on-hold-for-now-if-there-are-any-cuts-at-all-in-2025-after-decembers-sticky-consumer-inflation-report">Interest Rate Cuts &#8216;On Hold&#8230; If There Are Any At All In 2025&#8217; After December&#8217;s Sticky Consumer Inflation Report: Economists&nbsp;</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock.com

Earnings

Management

Movers

Insurance

UnitedHealth CEO Highlights Hospitals, Doctors, Pharma's Role In Soaring Health Care Costs

Shares of insurance and pharmacy benefit manager (PBM) companies such as Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>), Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) and CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) are trading lower Thursday, likely in reaction to UnitedHealth Group Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) disappointing fourth-quarter 2024 revenue results.
What To Know: UnitedHealth, the largest health insurer in the U.S., reported a revenue increase of 6.8% year-over-year to $100.8 billion, falling short of the consensus estimate of $101.76 billion.
UnitedHealth&#8217;s stock declined sharply, falling 6.04% to $510.59, as the earnings report highlighted concerns over its medical care ratio, which rose to 85.5% from 83.2% in 2023. This increase was attributed to factors such as Medicare funding reductions, member mix changes and the timing of Medicaid redeterminations.
UnitedHealth also reaffirmed its 2025 guidance, projecting $450 billion to $455 billion in revenue and adjusted EPS of $29.50 to $30.00.
The broader sector saw a ripple effect. The declines potentially reflect investor apprehension about sector-wide pressures, including reimbursement challenges and operational costs, spotlighted by UnitedHealth&#8217;s earnings report.
Price Actions: Closing Thursday, Centene stock dropped 0.44% to $62.87, CVS Health slid 0.15% to $51.96, Elevance Health fell 1.03% to $385.26 and Humana dropped 1.62% to $274.97 according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/01/43039835/dave-ramsey-breaks-down-how-a-40000-car-depreciates-by-16000-over-5-years-says-its-not-a-path-to-prosperity-even-on-an-80000-salary">Dave Ramsey Breaks Down How A $40,000 Car Depreciates By $16,000 Over 5 Years, Says It&#8217;s Not A Path To Prosperity, Even On An $80,000 Salary</a></li>
</ul>
Photo: Shutterstock.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?

Wall Street paused for a breather on Thursday, following Wednesday's big rally sparked by a softer-than-predicted December inflation report that fueled speculation on the Federal Reserve delivering interest rate <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43003047/stocks-rise-on-core-inflation-slowdown-banks-rally-after-strong-q4-earnings-treasury-yields-plummet">cuts during the year. </a>
By midday, stocks were little changed as attention shifted to the next major event: Donald Trump's inauguration as 47th U.S. president on Monday.
On the data front, December retail sales rose 0.4% from the previous month, a slower pace than November's 0.8% increase and below expectations of 0.6%. Jobless claims climbed by 16,000 to 217,000, slightly higher than <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43027744/retail-sales-slow-jobless-claims-rise-is-us-consumer-loosing-steam">the projected 210,000. </a>
See Also: <a href="https://www.benzinga.com/25/01/43020430/cathie-wood-sounds-alarm-over-inflation-pressures-and-consumer-woes-peter-schiff-flags-oil-spike-what-economists-are-saying">Cathie Wood Says Inflation Worries Dampen Expectations, Schiff Singles Out Wall Street For Swallowing Narrative Even As Prices Soar</a>
The weaker data sent Treasury yields lower, with the 10-year yield slipping four basis points to 4.61%, extending the previous day's 14-basis-point decline.
Falling yields helped gold climb 0.9% to $2,970 per ounce, reaching a two-month high as investors moved toward safe-haven assets. 
Semiconductor stocks stood out the best-performing industry, with the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) gaining 1.8%. Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) jumped more than 5% after delivering strong quarterly earnings, lifting the broader chip industry. Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) and ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) advanced 7% and 6%, respectively.
Oil prices pulled back 2.6%, giving up part of Wednesday's 4% gain. Traders speculated that Trump's policies could ease sanctions on Russian energy exports as part of a broader effort to negotiate peace in Ukraine. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged down 1% to $99,000, following a slight pullback across cryptocurrency markets.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,958.43</td>
<td>0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,255.53</td>
<td>0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,264.04</td>
<td>0.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,239.38</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated 12:40 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) remained unchanged at $593.10.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;flattened at $432.18.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) was unchanged at $516.54.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.1% to $224.31.</li>
<li>The&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 2.1%; the&nbsp;Health Care Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 0.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul>
<li>Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) fell 2% following quarterly earnings. Peer Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) rose 2.7%.</li>
<li>Other stocks reacting to earnings were UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), down 4.7%, Infosys Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>), down 5.2%, PNC Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>), down 2%, U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>), down 5.3%, M&amp;T Bank Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>), down 2.8%, First Horizon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>). </li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell by 3.6% after the EV giant announced reduced selling prices on its Cybertruck, in a strategy to revive demand. </li>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) dropped 3% after the European Commission's competition chief confirmed that the investigation into the company under the Digital Markets Act will move forward as scheduled, with enforcement anticipated by March 2024.</li>
</ul>
Check Out: 
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/01/43036258/polar-vortex-brings-winters-coldest-air-for-trumps-inauguration-day-what-it-means-for-utilities-retailers-energy-stocks">Polar Vortex Brings Winter&#8217;s Coldest Air For Trump&#8217;s Inauguration Day: What It Means For Utilities, Retailers, Energy Stocks</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Commodities

Treasuries

Econ #s

Economics

Tech

ETFs

$BTC

AMAT

ASML

SPDR Dow Jones Industrial Average ETF Trust

INFY

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSX:XL

Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What's Driving Markets Thursday?

Financial giants have made a conspicuous bullish move on UnitedHealth Group. Our analysis of options history for UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) revealed 27 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 22% showed bearish tendencies. Out of all the trades we spotted, 15 were puts, with a value of $769,655, and 12 were calls, valued at $738,696.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $310.0 and $575.0 for UnitedHealth Group, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for UnitedHealth Group's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of UnitedHealth Group's whale activity within a strike price range from $310.0 to $575.0 in the last 30 days. 
<h3>UnitedHealth Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737050459_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$122.0</td>
<td>$114.05</td>
<td>$117.25</td>
<td>$500.00</td>
<td>$199.3K</td>
<td>82</td>
<td align="right">0</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$62.8</td>
<td>$60.25</td>
<td>$61.68</td>
<td>$560.00</td>
<td>$123.3K</td>
<td>81</td>
<td align="right">20</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.5</td>
<td>$3.25</td>
<td>$3.25</td>
<td>$490.00</td>
<td>$97.5K</td>
<td>1.6K</td>
<td align="right">914</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$47.2</td>
<td>$43.65</td>
<td>$45.44</td>
<td>$480.00</td>
<td>$90.8K</td>
<td>398</td>
<td align="right">1</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$40.6</td>
<td>$37.85</td>
<td>$39.05</td>
<td>$500.00</td>
<td>$78.1K</td>
<td>1.2K</td>
<td align="right">47</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
<h3>Where Is UnitedHealth Group Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,631,547, with UNH's price down by -4.61%, positioned at $518.37.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About UnitedHealth Group</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $605.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on UnitedHealth Group, which currently sits at a price target of $600. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on UnitedHealth Group, which currently sits at a price target of $610. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for UnitedHealth Group, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

UnitedHealth Group Options Trading: A Deep Dive into Market Sentiment

On Thursday, UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance.
The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $6.72</a>. Revenues increased 6.8% year over year to $100.8 billion, missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43022980/unitedhealth-group-reports-2024-results" rel="noreferrer noopener">consensus of $101.76 billion</a>.
Fourth-quarter adjusted earnings from operations of $8.3 billion exclude the cyberattack direct response costs and <a target="_blank" href="https://www.benzinga.com/trading-ideas/previews/25/01/43014717/unitedhealth-group-q4-earnings-preview-first-report-since-insurance-ceos-murder" rel="noreferrer noopener">South American impacts</a>.
The full-year medical care ratio was 85.5% compared to 83.2% in 2023. The increase was primarily due to previously discussed items, including the revenue effects of CMS's Medicare funding reductions, member mix and timing of Medicaid redeterminations. A lower ratio typically indicates higher profitability.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43010888/ftc-says-unitedhealth-cvs-cigna-make-billions-via-pbms-on-specialty-drugs" rel="noreferrer noopener">FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs</a>
"The people of UnitedHealth Group remain focused on making high-quality, affordable health care more available to more people while making the health system easier to navigate for patients and providers, positioning us well for growth in 2025," said UNH CEO Andrew Witty.
UnitedHealthcare reported revenue of $74.1 billion, up from $70.8 billion a year ago. The number of consumers served with domestic commercial benefits grew by 2.4 million in 2024.
The number of people served by the company's offerings for seniors and people with complex needs grew to 9.4 million.
People served by the company's state-based community offerings moderated as expected to 7.4 million due to the now concluded Medicaid eligibility redeterminations process, partially offset by new and expanded customer relationships.
Optum reported $65.1 billion in revenue, up from $59.5 billion a year ago.
Optum Health served 4.7 million people with value-based care and expects to grow to serve an additional 650,000 patients in 2025.
Guidance: UnitedHealth reaffirms its 2025 sales guidance of $450 billion—$455 billion, compared to a consensus of $448.13 billion.
The company expects 2025 adjusted EPS of $29.50-$30.00 versus the consensus of $29.83 and operating cash flow of $32 billion—$33 billion.
Price Action: UNH stock is down 3.02% at $527 during the premarket session on the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43023028/stellantis-projects-9-shipment-decline-for-q4-amid-us-inventory-cuts" target="_blank" rel="noreferrer noopener">Stellantis Projects 9% Shipment Decline For Q4 Amid US Inventory Cuts</a></li>
</ul>
Photo: JHVEPhoto via Shutterstock

Guidance

UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls

WIIM

UnitedHealth Group shares are trading lower following a Q4 revenue miss.

U.S. stock futures were mixed on Thursday following Wednesday&#8217;s <a href="https://www.benzinga.com/news/earnings/25/01/43021827/dow-jumps-700-points-following-inflation-data-greed-index-remains-in-fear-zone">rally</a>. Futures of the S&amp;P 500, Nasdaq 100, and Dow Jones were higher, whereas the gauge of small-cap stocks Russell 2000 was trading lower in premarket trade.
Traders responded to better-than-expected inflation data on Wednesday as most stocks rallied. The headline Consumer Price Index rose 2.9% year-over-year in December, up from November's 2.7%, matching economist forecasts.
The 10-year Treasury note yielded 4.66%, while the two-year note yielded 4.28%. The CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a> indicated a 97.3% probability that the Federal Reserve will hold interest rates steady at its upcoming meeting on Jan. 31, 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.48%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.33%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.06%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.19%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) both experienced positive premarket trading on Thursday. SPY rose 0.35% to $594.86, and QQQ climbed 0.45% to $519.01, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
U.S. stocks surged on Wednesday, experiencing their largest single-day <a href="https://www.benzinga.com/news/earnings/25/01/43021827/dow-jumps-700-points-following-inflation-data-greed-index-remains-in-fear-zone">gain</a> since Nov. 6, 2024.
Inflation data released on Wednesday showed a slight uptick in consumer prices in December, matching economists&#8217; expectations. However, the monthly increase was the largest since March.
Several major banks, including JPMorgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Goldman Sachs Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and Citigroup Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) reported strong fourth-quarter earnings, with Citigroup also announcing a significant share buyback program.
Most sectors within the S&amp;P 500 experienced gains, particularly consumer discretionary, communication services, and financial stocks. Conversely, consumer staples stocks bucked the trend and closed lower.
The Dow Jones Industrial Average closed with a substantial gain of around 703 points. The S&amp;P 500 and Nasdaq Composite also recorded significant increases.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>2.45%</td>
<td>19,511.23</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.83%</td>
<td>5,949.91</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.65%</td>
<td>43,221.55</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.99%</td>
<td>2,263.29</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
After Wednesday&#8217;s rally, Charlie Bilello, the chief market strategist at Creative Planning said in an X post that about one-third of the S&amp;P 500&#8217;s composition was concentrated in the &#8216;Magnificent Seven&#8217; stocks. According to a chart shared by him the concentration in these stocks rose to 33.5% from 28% a year ago.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Over a third of the S&amp;P 500 is now concentrated in the &quot;Magnificent Seven&quot; stocks, up from a fifth of the index two years ago. Video: <a href="https://t.co/CRei7RqnLO">https://t.co/CRei7RqnLO</a> <a href="https://t.co/P69ATuGRHv">pic.twitter.com/P69ATuGRHv</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1879733848822403087?ref_src=twsrc%5Etfw">January 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about inflation, Collin Martin, director, of fixed income strategy at the Schwab Center for Financial Research said, &#8220;CPI was a step in the right direction, but we&#8217;ll need to see more reports like this for evidence that the disinflationary trend has resumed.&#8221;
At the same time, Liz Ann Sonders, the chief investment strategist, at Charles Schwab highlighted that the spread between S&amp;P 500's forward earnings yield and 10-year Treasury yield has reached a new 23-year low.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Spread between S&amp;P 500's forward earnings yield and 10y Treasury yield has reached new 23-year low <a href="https://t.co/SxoQO7TU9K">pic.twitter.com/SxoQO7TU9K</a>
&mdash; Liz Ann Sonders (@LizAnnSonders) <a href="https://twitter.com/LizAnnSonders/status/1876605073117122574?ref_src=twsrc%5Etfw">January 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
According to RMB Capital, the U.S. consumer remained resilient while U.S. government spending continued unchecked despite sticky inflation and higher interest rates.
&#8220;The incoming administration appears focused on the challenging task of bolstering economic growth while at the same time reducing the deficit. The most critical element of this endeavor will be curtailing the deficit while keeping longer-term yields contained, so as not to disrupt economic expansion,&#8221; it added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
<ul>
<li>On Thursday at 8:30 a.m., ET initial jobless claims data for the week ending Jan. 11 will be released.</li>
<li>December&#8217;s U.S. Retail Sales figures will be announced.</li>
<li>The Import Price Index for December will be published.</li>
<li>The Philadelphia Fed Manufacturing Survey for January will be released.</li>
<li>At 10:00 a.m., ET, the business inventories data for November will be released.</li>
<li>The Home Builder Confidence Index for January will be published.</li>
<li>On Friday, at 8:30 a.m. ET, the Housing Starts and Building Permits data for December will be released.</li>
<li>At 9:15 a.m., ET, the Industrial Production and Capacity Utilization figures for December will be announced.</li>
</ul>
Stocks In Focus:
<ul>
<li>Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) was up 0.38% in premarket on Thursday as Wall Street expects it to report quarterly earnings of 77 cents per share on revenue of $25.19 billion before the opening bell.</li>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) was up 1.49% ahead of its earnings before the opening bell. Analysts expect it to report quarterly earnings of $1.70 per share on revenue of $15.03 billion.</li>
<li>UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) was up 0.4% as Wall Street expects it to report quarterly earnings of $6.72 per share on revenue of $101.76 billion before the opening bell.</li>
<li>Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) was up 4.83% after it beat the fourth quarter revenue and EPS estimate. Its top client Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) was also up 2.04%.</li>
<li>Synovus Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) was up 0.46% after reporting upbeat fourth-quarter financial results on Wednesday.</li>
<li>Powell Max Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) was up 84.66% as it is targeting firms with between $1 million and $5 million in revenue to expand into the Hong Kong and Asian financial communications market.</li>
<li>Douyu International Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) was up 23.76% after naming Simin Ren as co-CEO and announced a special cash dividend of $9.94/ADS.</li>
<li>BigBear.ai Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) was up 14.45% as it appointed Kevin McAleenan as CEO and a member of the company&#8217;s board, effective as of Wednesday. McAleenan will replace Mandy Long, who is transitioning to an advisory role.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.30% to hover around $78.47 per barrel.
The gold spot index was up by 0.71% to $2,737.06 per ounce. The Dollar Index was down 0.01% at 109.083 level.
Asian markets closed higher on Thursday as Hong Kong&#8217;s Hang Seng, India&#8217;s S&amp;P BSE Sensex, China&#8217;s CSI 300, Australia&#8217;s ASX 200, Japan&#8217;s Nikkei 225 and South Korea&#8217;s Kospi index rose. European markets were also trading higher.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43021065/cash-app-parent-block-inc-eyes-395-upside-bofa-believes-us-centric-re-acceleration-story-will-drive-the-stock">Jack Dorsey&#8217;s Block Eyes Over 39% Upside: BofA Says US-Centric Re-Acceleration Story Will Drive The Stock</a></li>
</ul>
Photo courtesy: Wikimedia

Market Summary

Pre-Market Outlook

BBAI

DOYU

NVDA

PMAX

US Stocks Could Open Higher After Big Banks Report Strong Earnings: Mag 7 Now Account For A Third Of S&P 500's Market Capitalization, Raising Alarms

UnitedHealth Group Affirms 2025 Outlook With Sales Of $450B-$455B And Adjusted EPS Of $29.50-$30.00 Compared To Consensus Of $448.125B And $29.83, Respectively And Cash Flow From Operations Of $32B-$33B

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported quarterly earnings of $6.81 per share which beat the analyst consensus estimate of $6.72 by 1.34 percent. The company reported quarterly sales of $100.81 billion which missed the analyst consensus estimate of $101.76 billion by 0.94 percent. This is a 6.76 percent increase over sales of $94.43 billion the same period last year.

UnitedHealth Group Q4 2024 Adj EPS $6.81 Beats $6.72 Estimate, Sales $100.81B Miss $101.76B Estimate

The CNN Money Fear and Greed index remained in the &#8220;Fear&#8221; zone on Wednesday.
U.S. stocks settled higher on Wednesday, with all three major indices recording their best day since Nov. 6.
On the economic data front, the headline Consumer Price Index rose 2.9% year-over-year in December, up from November&#8217;s 2.7%, matching economist forecasts. On a monthly basis, headline inflation increased 0.4%, accelerating from the 0.3% surge in November and marking the largest monthly rise since March 2024.
JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) reported upbeat fourth-quarter FY24 results. Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) reported better-than-expected fourth-quarter financial results. Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) also reported better-than-expected fourth-quarter financial results and announced a $20 billion buyback.
Most sectors on the S&amp;P 500 closed on a positive note, with consumer discretionary, communication services, and financials stocks recording gains on Wednesday. However, consumer staples stocks bucked the overall market trend, closing the session slightly lower.
The Dow Jones closed higher by around 703 points to 43,221.55 on Wednesday. The S&amp;P 500 rose 1.83% to 5,949.91, while the Nasdaq Composite climbed 2.45% at 19,511.23 during Tuesday's session.
Investors are awaiting earnings results from Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), and UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 29.11, the index remained in the &#8220;Fear&#8221; zone on Wednesday, versus a prior reading of 29.14.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Dow Jumps 700 Points Following Inflation Data: Greed Index Remains In 'Fear' Zone

<h3>Companies Reporting Before The Bell</h3>
• Insteel Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIIN#NYSE">IIIN</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $117.45 million. 
• Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is likely to report quarterly earnings at $2.16 per share on revenue of $26.38 billion. 
• Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $4.93 billion. 
• Bank7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSVN#NASDAQ">BSVN</a>) is expected to report quarterly earnings at $1.05 per share on revenue of $23.50 million. 
• PNC Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) is expected to report quarterly earnings at $3.30 per share on revenue of $5.49 billion. 
• M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) is projected to report quarterly earnings at $3.74 per share on revenue of $2.34 billion. 
• UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) is expected to report quarterly earnings at $6.92 per share on revenue of $101.09 billion. 
• First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $825.23 million. 
• Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) is projected to report quarterly earnings at $0.79 per share on revenue of $25.22 billion. 
• Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.35 billion. 
• U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) is estimated to report quarterly earnings at $1.01 per share on revenue of $6.93 billion. 
<h3>Companies Reporting After The Bell</h3>
• JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) is expected to report quarterly earnings at $1.62 per share on revenue of $3.15 billion. 
• Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) is projected to report quarterly earnings at $1.16 per share on revenue of $175.71 million. 
• Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>) is expected to report quarterly earnings at $1.44 per share on revenue of $407.32 million. 
• RF Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RFIL#NASDAQ">RFIL</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $17.85 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSVN

IIIN

INDB

JBHT

RFIL

Earnings Scheduled For January 16, 2025

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) to report quarterly earnings at 77 cents per share on revenue of $25.19 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Bank of America shares gained 0.8% to $47.46 in after-hours trading.</li>
<li>Synovus Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) reported upbeat fourth-quarter financial results on Wednesday. Synovus Financial shares rose 0.5% to $56.24 in the after-hours trading session.</li>
<li>Analysts expect Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) to post quarterly earnings at $1.70 per share on revenue of $15.03 billion. The company will release earnings before the markets open. Morgan Stanley shares gained 1.3% to $132.20 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Taiwan Semiconductor Mfg. Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) said net profit climbed 57% year-over-year to a record T$374.68 billion ($11.38 billion). TSMC shares gained 1.3% to $209.40 in the after-hours trading session.</li>
<li>Analysts expect UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) to post quarterly earnings at $6.72 per share on revenue of $101.76 billion before the opening bell. UnitedHealth shares gained 0.3% to $544.89 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Thursday

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 15 years by 8.74% on an annualized basis producing an average annual return of 20.51%. Currently, UnitedHealth Group has a market capitalization of $500.10 billion. 
Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 15 years ago, it would be worth $15,728.51 today based on a price of $543.42 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736984708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 15 Years

Barclays lowered the firm's price target on UnitedHealth (UNH) to $642 from $655 and keeps an Overweight rating on the shares. The firm updated the...

UnitedHealth price target lowered to $642 from $655 at Barclays

UnitedHealth CEO: American healthcare needs to be "less complex and less confusing'

RBC Capital analyst Ben Hendrix reiterated a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of $655.00. The co...

UnitedHealth (UNH) Receives a Buy from RBC Capital

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target remains...

UnitedHealth's Strategic Positioning and 2025 Outlook Supports Buy Rating Despite MLR Challenges

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on UnitedHealth (UNH – Research Report), Insmed (INSM –...

Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Insmed (INSM)

UnitedHealth: The Anatomy Of A Bearish Setup With Parameters To Confirm Or Deny (Technical Analysis)

In a report released today, John Ransom from Raymond James reiterated a Buy rating on UnitedHealth (UNH – Research Report), with a price target of ...

Raymond James Keeps Their Buy Rating on UnitedHealth (UNH)

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price targe...

UnitedHealth (UNH) Gets a Buy from Oppenheimer

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target...

UnitedHealth (UNH) Receives a Buy from Cantor Fitzgerald

Alignment Healthcare is latest to sue Medicare over Star Ratings

ALHC

INSM

PRVA

Press Releases

UnitedHealth Group Reports Third Quarter 2024 Results

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

UnitedHealth Group to Host 2024 Investor Conference

UnitedHealth Group Updates Business Outlook Ahead of Investor Conference

UnitedHealth Group Statement on Today's Events

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

Media Advisory: UnitedHealth Group Responds to Misinformation

Legal

Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

Comments

UnitedHealth Group

ニュース

最新ニュース UnitedHealth Group (NYSE:UNH) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル